Cargando…

Influenza H1 Mosaic Hemagglutinin Vaccine Induces Broad Immunity and Protection in Mice

Annually, influenza A virus (IAV) infects ~5–10% of adults and 20–30% of children worldwide. The primary resource to protect against infection is by vaccination. However, vaccination only induces strain-specific and transient immunity. Vaccine strategies that induce cross-protective immunity against...

Descripción completa

Detalles Bibliográficos
Autores principales:	Corder, Brigette N., Bullard, Brianna L., DeBeauchamp, Jennifer L., Ilyushina, Natalia A., Webby, Richard J., Weaver, Eric A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6963302/ https://www.ncbi.nlm.nih.gov/pubmed/31771231 http://dx.doi.org/10.3390/vaccines7040195

Ejemplares similares

Epigraph hemagglutinin vaccine induces broad cross-reactive immunity against swine H3 influenza virus
por: Bullard, Brianna L., et al.
Publicado: (2021)

An epitope-optimized human H3N2 influenza vaccine induces broadly protective immunity in mice and ferrets
por: Bullard, Brianna L., et al.
Publicado: (2022)

Adenoviral-Vectored Centralized Consensus Hemagglutinin Vaccine Provides Broad Protection against H2 Influenza a Virus
por: Petro-Turnquist, Erika M., et al.
Publicado: (2022)

Strategies Targeting Hemagglutinin as a Universal Influenza Vaccine
por: Bullard, Brianna L., et al.
Publicado: (2021)

A Decade in Review: A Systematic Review of Universal Influenza Vaccines in Clinical Trials during the 2010 Decade
por: Corder, Brigette N., et al.
Publicado: (2020)

Centralized Consensus Hemagglutinin Genes Induce Protective Immunity against H1, H3 and H5 Influenza Viruses
por: Webby, Richard J., et al.
Publicado: (2015)

Protection against Divergent Influenza H1N1 Virus by a Centralized Influenza Hemagglutinin
por: Weaver, Eric A., et al.
Publicado: (2011)

A Single-Cycle Adenovirus Type 7 Vaccine for Prevention of Acute Respiratory Disease
por: Bullard, Brianna L., et al.
Publicado: (2019)

Species D Adenoviruses as Oncolytic Viral Vectors
por: Bullard, Brianna L., et al.
Publicado: (2020)

Mosaic nanoparticle display of diverse influenza virus hemagglutinins elicits broad B cell responses
por: Kanekiyo, Masaru, et al.
Publicado: (2019)

Mosaic Hemagglutinin-Based Whole Inactivated Virus Vaccines Induce Broad Protection Against Influenza B Virus Challenge in Mice
por: Liu, Yonghong, et al.
Publicado: (2021)

H5N1 influenza vaccine induces a less robust neutralizing antibody response than seasonal trivalent and H7N9 influenza vaccines
por: Wong, Sook-San, et al.
Publicado: (2017)

Efficacy of a T Cell-Biased Adenovirus Vector as a Zika Virus Vaccine
por: Bullard, Brianna L., et al.
Publicado: (2018)

Baculovirus Displaying Hemagglutinin Elicits Broad Cross-Protection against Influenza in Mice
por: Sim, Sang-Hee, et al.
Publicado: (2016)

Histone Deacetylase 6 Knockout Mice Exhibit Higher Susceptibility to Influenza A Virus Infection
por: Zanin, Mark, et al.
Publicado: (2020)

Characterization of a Species E Adenovirus Vector as a Zika virus vaccine
por: Bullard, Brianna L., et al.
Publicado: (2020)

Targeting Hemagglutinin: Approaches for Broad Protection against the Influenza A Virus
por: Zhang, Yun, et al.
Publicado: (2019)

Structural insights into the broad protection against H1 influenza viruses by a computationally optimized hemagglutinin vaccine
por: Dzimianski, John V., et al.
Publicado: (2023)

Vaccination with Deglycosylated Modified Hemagglutinin Broadly Protects against Influenza Virus Infection in Mice and Ferrets
por: Zhang, Limin, et al.
Publicado: (2022)

Influenza chimeric hemagglutinin structures in complex with broadly protective antibodies to the stem and trimer interface
por: Zhu, Xueyong, et al.
Publicado: (2022)

Broadly Protective Monoclonal Antibodies against H3 Influenza Viruses following Sequential Immunization with Different Hemagglutinins
por: Wang, Taia T., et al.
Publicado: (2010)

Influenza A virus hemagglutinin mutations associated with use of neuraminidase inhibitors correlate with decreased inhibition by anti-influenza antibodies
por: Ilyushina, Natalia A., et al.
Publicado: (2019)

Autoreactivity profiles of influenza hemagglutinin broadly neutralizing antibodies
por: Bajic, Goran, et al.
Publicado: (2019)

A mosaic hemagglutinin-based influenza virus vaccine candidate protects mice from challenge with divergent H3N2 strains
por: Broecker, Felix, et al.
Publicado: (2019)

In vitro evolution of an influenza broadly neutralizing antibody is modulated by hemagglutinin receptor specificity
por: Wu, Nicholas C., et al.
Publicado: (2017)

The immune correlates of protection for an avian influenza H5N1 vaccine in the ferret model using oil-in-water adjuvants
por: Wong, Sook-San, et al.
Publicado: (2017)

Broadly-Reactive Neutralizing and Non-neutralizing Antibodies Directed against the H7 Influenza Virus Hemagglutinin Reveal Divergent Mechanisms of Protection
por: Tan, Gene S., et al.
Publicado: (2016)

Passive immunoprophylaxis and therapy with humanized monoclonal antibody specific for influenza A H5 hemagglutinin in mice
por: Hanson, Brendon J, et al.
Publicado: (2006)

A chimeric influenza hemagglutinin delivered by parainfluenza virus 5 vector induces broadly protective immunity against genetically divergent influenza a H1 viruses in swine
por: Li, Zhuo, et al.
Publicado: (2020)

Molecular Docking of Broad-Spectrum Antibodies on Hemagglutinins of Influenza A Virus
por: Le, Khanh PB, et al.
Publicado: (2019)

Chimeric hemagglutinin split vaccines elicit broadly cross-reactive antibodies and protection against group 2 influenza viruses in mice
por: Puente-Massaguer, Eduard, et al.
Publicado: (2023)

Evidence of Infection with H4 and H11 Avian Influenza Viruses among Lebanese Chicken Growers
por: Kayali, Ghazi, et al.
Publicado: (2011)

Recombinant influenza H1, H5 and H9 hemagglutinins containing replaced H3 hemagglutinin transmembrane domain showed enhanced heterosubtypic protection in mice
por: Liu, Qiliang, et al.
Publicado: (2014)

Efficacy of an Adenoviral Vectored Multivalent Centralized Influenza Vaccine
por: Lingel, Amy, et al.
Publicado: (2017)

How single mutations affect viral escape from broad and narrow antibodies to H1 influenza hemagglutinin
por: Doud, Michael B., et al.
Publicado: (2018)

Broadly Reactive H2 Hemagglutinin Vaccines Elicit Cross-Reactive Antibodies in Ferrets Preimmune to Seasonal Influenza A Viruses
por: Reneer, Z. Beau, et al.
Publicado: (2021)

Seasonal quadrivalent mRNA vaccine prevents and mitigates influenza infection
por: Kackos, Christina M., et al.
Publicado: (2023)

Vaccination with viral vectors expressing NP, M1 and chimeric hemagglutinin induces broad protection against influenza virus challenge in mice
por: Asthagiri Arunkumar, Guha, et al.
Publicado: (2019)

Bioprocess development for universal influenza vaccines based on inactivated split chimeric and mosaic hemagglutinin viruses
por: Puente-Massaguer, Eduard, et al.
Publicado: (2023)

Vaccination with a Recombinant H7 Hemagglutinin-Based Influenza Virus Vaccine Induces Broadly Reactive Antibodies in Humans
por: Stadlbauer, Daniel, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_lek34q3obn4374hgdubih9tfei